Corbin Davis
Authored Items
By Corbin Davis
TOP - March 2020, Vol 13, No 2
San Francisco, CA—According to results from a retrospective analysis of nearly 12,000 patients with cancer, increased social support may function as an analgesic and help to mitigate pain. Read More ›
By Corbin Davis
TOP - January 2020, Vol 13, No 1
San Francisco, CA—Cannabis has been credited as a medicinal plant with benefits ranging from pain and inflammation relief to epileptic seizure reduction to insomnia and anxiety cures, but the evidence is still limited, particularly in the setting of advanced cancer. Read More ›
By Corbin Davis
TOP - August 2018, Vol 11, No 2
Although the FDA approval of the 2 kinase inhibitors, lenvatinib (Lenvima) and sorafenib (Nexavar), has improved progression-free survival (PFS) rates, the responses to treatment with these agents are not durable and more treatments are needed.
Read More ›By Corbin Davis
TOP - August 2018, Vol 11, No 2
Current National Comprehensive Cancer Network guidelines recommend initiating radiation therapy within 6 weeks of tumor resection, but the benefits of shorter time to radiation therapy, including locoregional control and survival, remain inconclusive.
Read More ›